Stock Research: DaVita

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

DaVita

NYSE:DVA US23918K1088
47
  • Value
    51
  • Growth
    31
  • Safety
    Safety
    78
  • Combined
    57
  • Sentiment
    48
  • 360° View
    360° View
    47
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

DaVita Inc. is a healthcare provider focused on kidney care services. It primarily operates in kidney care, providing dialysis and administrative services, and integrated kidney care services for patients with chronic kidney failure and end-stage kidney disease. The company operates in the United States and internationally. In the last fiscal year, the company had a market cap of $10610 million, profits of $4217 million, revenue of $12816 million, and 76000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 47 (better than 47% compared with alternatives), overall professional sentiment and financial characteristics for the stock DaVita are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for DaVita. The consolidated Value Rank has an attractive rank of 78, which means that the share price of DaVita is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 78% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 51. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 48. Professional investors are more confident in 52% other stocks. The consolidated Growth Rank also has a low rank of 31, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 69 of its competitors have better growth. ...read more

more
Index
Dividends USA
Employee Focus US
Low Waste
D.J. US Health Care
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 4-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 65 42 76
Growth
31 53 43 45
Safety
Safety
51 23 27 52
Sentiment
48 41 71 33
360° View
360° View
47 39 44 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
7 13 7 5
Opinions Change
76 22 72 50
Pro Holdings
n/a 85 100 79
Market Pulse
31 52 38 36
Sentiment
48 41 71 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 65 42 76
Growth
31 53 43 45
Safety Safety
51 23 27 52
Combined
57 46 16 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
78 66 88 71
Price vs. Earnings (P/E)
56 53 54 66
Price vs. Book (P/B)
95 1 6 11
Dividend Yield
1 75 1 84
Value
78 65 42 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
16 26 19 24
Profit Growth
38 43 70 52
Capital Growth
51 46 34 60
Stock Returns
45 75 87 53
Growth
31 53 43 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
19 13 14 16
Refinancing
72 40 42 59
Liquidity
50 47 54 63
Safety Safety
51 23 27 52

Similar Stocks

Discover high‑ranked alternatives to DaVita and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.